On March 12th, 1655 Shiloh Road Suite B
Educational Seminar On Tinnitus And Lenire
For tinnitus sufferers and healthcare providers
What To Expect
- An overview of tinnitus: its causes and challenges
- Introduction to Lenire: the first and only FDA-approved tinnitus treatment device
- How Lenire works and its clinical benefits
- Q&A session with Dr. Ross O’Neill
- Refreshments
- Door Prizes
What is Lenire?
Lenire is a device that uses bimodal neuromodulation to reduce the severity of tinnitus.
It delivers mild pulses to the tongue combined with sound played through headphones to help your brain pay less attention to tinnitus.
What is the research behind Lenire?
Lenire is the first device of its kind to receive a grant of approval from the FDA to treat tinnitus. This follows a large-scale clinical trial designed to meet the FDA's requirements during which 83% of patients recommended Lenire for the treatment of tinnitus. The largescale trial's results were consistent with real-world evidence from 204 patients*.
We invite you to join us March 12th
Reserve your spot today!